Recently, the EqualOcean Health dropped a bombshell of the "CHS 2023 China Health Industry List" series. With its technical innovation strength and rich practical experience, DHC has been named as the "TOP10 Enterprises with Investment Value in Health Industry", demonstrating the company's influence and value creativity in the medical industry.

As one of the most concerned annual lists of big health industries in China, "CHS 2023 China Big Health Industries List" is committed to multi-level, multi-dimensional and professional selection of enterprises, investors and the most innovative figures with vitality and innovation genes in China's big health industries to tap the core strength in the process of medical innovation. After several rounds of selection and combined with the opinions of professional analysts, the list of "CHS 2023 China Top Health Industries" is officially released.

In recent years, to promote the development of "digital economy" and improve the modernization level of China's digital economy governance system and governance ability is of great significance for the construction of a new development pattern, the construction of a modern economic system and the construction of new competitive advantages of the country. Among many industrial chains of digital economy, digital medical industry in China is shaping a new industrial pattern with its unique strength and vitality, which contributes great value to the public health and well-being.

Under the new situation, as the main body of providing medical services, hospitals should actively promote digital transformation, use big data and artificial intelligence to empower high-quality development, and achieve double improvement in diagnosis and treatment and scientific research. However, in practice, it may face data governance problems and application dilemmas.

As a leader in medical big data and artificial intelligence, DHC is one of the few companies in China that can realize closed-loop fusion of multi-component and multi-modal big data. Relying on its independent research and development and technical innovation ability, it can break through the barriers between multi-modal data such as clinical text, imaging, and genomics, and assist hospitals to better manage multi-source heterogeneous medical data by virtue of the full-chain, one-stop intelligent data processing ability, and shift from single-modal to multi-modal big data fusion development. Meanwhile, the application of innovative technologies in the medical field is actively promoted through the full implementation of multi-level, multi-scenario big data AI solutions.

Since its establishment, DHC has focused on the development of big data, artificial intelligence, multimodal and other forward-looking technologies, adhered to the construction of a medical terminology standard system in accordance with international common standards, formed a multi-omics, multi-modal big data fusion-governance-analysis closed loop, and deepened the whole process of clinical "screening, diagnosis, treatment, management and research", continuously promoting the overall improvement of clinical value and scientific research value of medical institutions. At present, more than1800 customers from cooperative hospitals have accumulated data management experience of more than 300 million patient-times. We have carried out more than 40 national scientific research projects and major national projects, participated in the construction of several national database platforms for critical illness specific illnesses, supported the development of multiple specific illness standard data sets, and focused on supporting the construction of a national data system and research collaboration in such disciplines as oncology, cardiology, nephrology, critical medicine, rare illness and clinical genetics, epidemiology, gynecologic oncology, childhood oncology, and rheumatology, applying medical big data and artificial intelligence technology to multiple clinical fields, mining the clinical and scientific research value of multimodal big data, and promoting the high-quality development of medical research in our country.

This award highlights the industry's recognition and affirmation of DHC. DHC will also take this opportunity to persist in scientific and technological innovation, revitalize data assets, realize the closed-loop integration of multi-group and multi-mode big data, improve the level of diagnosis and treatment and scientific research of medical institutions at all levels, promote the digital transformation and upgrading of the medical industry with scientific and technological strength, and create greater value for the high-quality development of social economy.